PLASMA piRNA COMBINATION FOR EARLY DIAGNOSIS OF GASTRIC CANCER AND APPLICATION THEREOF

APPLICATION OF ZINC FINGER PROTEIN 217 GENE IN PREPARING MEDICINES FOR TREATING OSTEOPOROSIS

RNAI CONSTRUCTS FOR INHIBITING PNPLA3 EXPRESSION AND METHODS OF USE THEREOF

PALMITOYLATION OF THE ALTERNATIVE AMINO TERMINUS OF THE BTK-C ISOFORM CONTROLS SUBCELLULAR DISTRIBUTION AND SIGNALING

NUCLEIC ACID, PHARMACEUTICAL COMPOSITION AND SIRNA CONJUGATE CONTAINING THE NUCLEIC ACID, PREPARATION METHOD THEREFOR, AND USE THEREOF

METHOD OF TREATING A MAMMAL WITH DIABETES ASSOCIATED KIDNEY DISEASE USING LOCAL ADMINISTRATION OF STEM CELLS WITH TRANSIENTLY REDUCED p53

COMPOSITIONS AND METHODS FOR TREATING HEPATITIS B VIRUS (HBV) INFECTION AND HBV-ASSOCIATED DISEASES

INHIBITION OF FOLLISTATIN

INHIBITORS OF EXPRESSION AND/OR FUNCTION

METHODS FOR TREATING NEUROINFLAMMATION

METHODS AND COMPOSITIONS FOR TREATING FIBROSIS

METHODS OF DELIVERING THERAPEUTIC AGENTS, AND LIPID COMPOSITIONS

METHODS AND COMPOSITIONS FOR MODULATING FIBRINOGEN

COMPOSITIONS AND THERAPEUTIC AGENTS FOR MODULATING INFLAMMATORY RESPONSES ON BOTH TUMOR AND IMMUNE CELLS

PRODUCTS AND COMPOSITIONS

INTERFERING RNA FOR INHIBITING PCSK9 GENE EXPRESSION AND USE THEREOF

TREATMENT OF MST1 RELATED DISEASES AND DISORDERS

MUCIN-5B (MUC5B) TARGETED SIRNA AND ANTISENSE OLIGONUCLEOTIDES AND METHODS OF USE THEREOF

CONJUGATES FOR TISSUE-SPECIFIC OLIGONUCLEOTIDE DELIVERY

NUCLEIC ACID FOR TRANSFECTION

PRODUCTS AND COMPOSITIONS

RNAI CONSTRUCTS FOR INHIBITING SCAP EXPRESSION AND METHODS OF USE THEREOF

ANTISENSE OLIGONUCLEOTIDE FOR TREATING MELANOMA

COMPOSITIONS FOR TREATING SYNGAP-1 RELATED NEURODEVELOPMENTAL DISORDERS

Facile Assembly of Soft Nanoarchitectures and Co-Loading of Hydrophilic and Hydrophobic Molecules via Flash Nanoprecipitation

SYSTEMIC DELIVERY OF MYOSTATIN SHORT INTERFERING NUCLEIC ACIDS (SINA) CONJUGATED TO A LIPOPHILIC MOIETY

GELATIN AND LIPIDOID GENETIC DELIVERY PARTICLE

COMPOSITIONS OF LIPID NANOPARTICLES FOR PLASMID DNA DELIVERY TO THE LIVER AND METHODS FOR PREPARING THE SAME

PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING MALIGNANT BREAST CANCER

INHIBITORS OF EXPRESSION AND/OR FUNCTION

17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 13 (HSD17B13) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

TREATMENT OF CARDIOVASCULAR DISEASE

DOUBLE-STRANDED RNA MOLECULE AND PHARMACEUTICAL USE THEREOF

SINGLE-STRANDED LOOP OLIGONUCLEOTIDES

miRNA-BASED COMPOSITIONS AND METHODS OF USE THEREOF

HUMAN ANTIBODIES TO THE GLUCAGON RECEPTOR

AMINOOXY CLICK CHEMISTRY (AOCC): A VERSATILE CONJUGATION APPROACH

METHOD OF SYNTHESIS OF AN IONIZABLE CATIONIC LIPID

NOVEL LIPIDS BASED ON OLIGO-y-GLUTAMIC ACID DERIVATIVES AND LIPID NANOPARTICLES CONTAINING THE SAME, AND USES THEREOF

COMPOSITIONS AND METHODS FOR TREATING HEPATITIS D VIRUS (HDV) INFECTION AND ASSOCIATED DISEASES

METHODS AND COMPOSITIONS RELATING TO TREATMENT OF CNS DISEASES

ONE-STEP CONSTRUCTION OF ALLOGENIC CAR-NK CELLS WITH INCREASED ANTI-TUMOR CYTOTOXICITY AND RESISTANCE TO HOST CELL REJECTION

REGULATION OF TYPE I IFN SIGNALING BY TARGETING A DECOY RECEPTOR

SYNTHETIC TRANSFER RNA WITH MODIFIED NUCLEOTIDES

COMPOSITIONS AND METHODS FOR INHIBITING CYTOCHROME P450 FAMILY 7 SUBFAMILY A MEMBER 1 (CYP7A1) EXPRESSION

OLIGONUCLEOTIDE-BASED DELIVERY VEHICLE FOR OLIGONUCLEOTIDES AGENTS AND METHODS OF USE THEREOF

CERTAIN DUX4 INHIBITORS AND METHODS OF USE THEREOF

COMPOSITION AND METHOD FOR INHIBITING EXPRESSION OF PROTEIN LPA(APO(A))

METHODS AND COMPOSITIONS FOR INHIBITING MISMATCH REPAIR

MUC5AC-TARGETED ANTISENSE OLIGONUCLEOTIDES AND RELATED METHODS FOR MODULATING MUCIN EXPRESSION

MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING DYSTROPHINOPATHIES

NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF

IMMUNOSTIMULATORY NANOPARTICLE

COMPOSITIONS AND METHODS FOR DELIVERY OF BIOMACROMOLECULE AGENTS

ISOLATION OF ANTI-INFLAMMATORY NEUTROPHIL OR MONOCYTE SUBSET AND USE IN TREATING CARDIOVASCULAR DISEASES

COMPOSITIONS AND METHODS OF MODULATING XANTHINE DEHYDROGENASE

USE OF ANTISENSE OLIGONUCLEOTIDE IN PREPARATION OF DRUG FOR TREATING DISEASE CAUSED BY ABNORMAL THYROID

EPICARDIAL CELL REGENERATION PROMOTER AND METHOD FOR PROMOTING EPICARDIAL CELL REGENERATION

VARIANT RNAi

STAT3 TARGETING OLIGONUCLEOTIDES AND USES THEREOF

SUGAR-CONJUGATED LIPID NANOPARTICLES FOR TARGETED DELIVERY OF SIRNA TO HEPATOCYTES

Compositions and Methods for RNA Editing

COMPOSITIONS AND METHODS FOR TREATING RETINAL DISEASES

Oligonucleotide Terminal Phosphate Derivatives and Method of Use

ACTIN-BINDING LIM PROTEIN 3 (ABLIM3) iRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOF

RNA COMPOSITIONS AND THERAPEUTIC METHODS THEREOF

TREATMENT OF CARDIOVASCULAR DISEASE

COMPOSITIONS FOR TREATING AND/OR PREVENTING CELL OR TISSUE NECROSIS SPECIFICALLY TARGETING CATHEPSIN C AND/OR CELA1 AND/OR CELA3A AND/OR STRUCTURALLY RELATED ENZYMES THERETO

FN3 DOMAIN-siRNA CONJUGATES AND USES THEREOF

CATIONIC LIPIDS CONTAINING SILICON

OLIGONUCLEOTIDES FOR PRNP MODULATION

METHODS AND COMPOSITIONS FOR TREATING A PROPROTEIN CONVERTASE SUBTILISIN KEXIN (PCSK9) GENE-ASSOCIATED DISORDER

Allele-Specific Silencing of Transforming Growth Factor Beta Induced Gene with R124H Mutation Using Short Interfering RNA

LPA inhibitors and uses thereof

CO-DELIVERY OF INHIBITORY NUCLEIC ACIDS AND GENOME EDITORS FOR TUMOR THERAPY

BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR TRANSFERRIN RECEPTOR 1 (TfR1)

SERUM AMYLOID P COMPONENT (APCS) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

TOPICAL PATCH COMPOSITION FOR TARGETED SIRNA NANOPLEX DELIVERY AND GENE THERAPIES AND METHOD OF MAKING AND USE THEREOF

COMPOSITION FOR PREVENTING OR TREATING CANCER, CONTAINING LIPID NANOPARTICLES

NOVEL FISH TOTIVIRUS

Methods for Suppression of Gene Silencing in Plants

BIS-RNAI COMPOUNDS FOR CNS DELIVERY

ANTI-CANCER AGENTS

CIRCRNAS FOR GENE SILENCING

ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES

MSI2 AS A THERAPEUTIC TARGET FOR THE TREATMENT OF MYOTONIC DYSTROPHY

CATIONIC SULFONAMIDE AMINO LIPIDS AND AMPHIPHILIC ZWITTERIONIC AMINO LIPIDS

LIPID NANOPARTICLES COMPRISING MANNOSE OR USES THEREOF

Olfactory Delivery Scaffolds Using Antisense Oligonucleotides and Methods for Making and Using Same

METHODS FOR THE IDENTIFICATION AND TREATMENT OF SEVERE FORMS OF COVID-19

PHARMACEUTICAL COMBINATIONS FOR TREATMENT OF HBV

NUCLEIC ACID-POLYPEPTIDE NANO-PHARMACEUTICAL COMPOSTION FOR TREATING AND PREVENTING HUMAN PAPILLOMA VIRUS INFECTION

RNAI AGENTS TARGETING CIDEB AND RELATED METHODS

COMPOSITIONS AND METHODS FOR MODULATING APOC3 EXPRESSION

METHOD OF TREATING, AMELIORATING AND/OR PREVENTING POLYCYSTIC KIDNEY DISEASE

COMPOSITIONS AND METHODS FOR TREATING LIVER DISEASES WITH siRNAS TARGETING TBX3

COMPOSITIONS AND METHODS OF MODULATING RNA AND PROTEIN INTERACTIONS

NANO-IN-MICRO ENCAPSULATED siRNA DRY POWDER, METHOD FOR PRODUCING THE SAME AND USE OF A POWDER FORMULATION

COMPOSITIONS AND METHODS FOR TREATING LIVER DISEASES WITH SIRNAS TARGETING SMYD2

MUSK-TARGETING OLIGONUCLEOTIDES

KETOHEXOKINASE (KHK) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

TREATMENT OF H3.3-MUTANT BRAIN CANCER WITH PNKP INHIBITORS

COMPOSITION AND METHOD FOR INHIBITING EXPRESSION OF PROTEIN LPA(APO(A))

SIGNAL ACTIVATABLE NUCLEIC ACID COMPLEXES

NON-HALLUCINOGENIC PSYCHEDELIC FUNGI

MARKERS SELECTIVELY DEREGULATED IN TUMOR-INFILTRATING REGULATORY T CELLS

METHODS AND COMPOSITIONS FOR TREATING ATHEROSCLEROSIS

SIRNA OR SALT THEREOF AND MEDICAMENT FOR INHIBITING EXPRESSION OF TMPRSS6 GENE, AND USE THEREOF

POLYNUCLEIC ACID MOLECULES FOR INHIBITING EXPRESSION OF FXI, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF

XANTHINE DEHYDROGENASE (XDH) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

DOUBLE-STRANDED RNA MOLECULE FOR ADMINISTRATION TO THE EYE

MODIFIED OLIGONUCLEOTIDES

MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING DYSTROPHINOPATHIES

SARM1 RNAi AGENTS

ANTIMICROBIAL PEPTIDE DERIVATIVE AND USE THEREOF

LIPID NANOPARTICLES, NUCLEIC ACIDS, AND METHODS OF USE

piRNA-BASED CONSTRUCTS FOR REGULATING GENE EXPRESSION AND METHODS OF USE THEREOF

COMPOSITIONS AND METHODS FOR TREATMENT OF PRION DISEASES

PNPLA3-TARGETING SHORT INTERFERING RNA (SIRNA) MOLECULES AND USES THEREOF

UNIVERSAL NON-TARGETING SIRNA COMPOSITIONS AND METHODS OF USE THEREOF

COMPOSITIONS AND METHODS FOR INHIBITING STAG1 EXPRESSION AND USES THEREOF

Targeting Ligands For Therapeutic Compounds

CAR-EXPRESSING CELLS AGAINST MULTIPLE TUMOR ANTIGENS AND USES THEREOF

GLYCAN CONJUGATE COMPOSITIONS AND METHODS

METHOD OF DELIVERY OF DNA OR RNA CARGO USING UNSHIELDED LIPID NANOPARTICLES AND COMPOSITIONS THEREOF

POLY-GA PROTEINS IN ALZHEIMER’S DISEASE

Methods Of Treating Decreased Bone Mineral Density With Cluster Of Differentiation 109 (CD109) Inhibitors

MULTI-TARGETED SINGLE ENTITY CONJUGATES

COMPOSITIONS AND METHODS FOR TREATING LIVER DISEASES WITH SIRNAS TARGETING CIDEB

METHODS FOR IMPROVING ADENO-ASSOCIATED VIRUS (AAV) DELIVERY

Methods and Compositions for Inhibiting the Growth and/or proliferation of MYC-Driven Tumor Cells

METHODS AND SYSTEMS FOR IDENTIFYING AND VALIDATING A GENE COMBINATION ASSOCIATED WITH A TRAIT AND USES THEREOF

Use of Trinucleotide Repeat RNAs To Treat Cancer

PRODUCTS AND METHODS FOR INHIBITION OF EXPRESSION OF DYNAMIN-1 VARIANTS

Nucleic acids for inhibiting expression of MASP-2 in a cell

Methods For The Treatment Of ANGPTL3-Related Diseases And Disorders

DELIVERY OF HYDROPHOBIC ACTIVE AGENT PARTICLES

METHODS AND COMPOSITIONS FOR NON-MYELOABLATIVE BONE MARROW RECONSTITUTION

COMPOUNDS TO INHIBIT YTHDF2, T HELPER CELLS LACKING EXPRESSION OF YTHDF2, AND METHODS TO TREAT CANCER

COMPOSITIONS AND METHODS FOR TREATMENT OF SEPSIS-RELATED DISORDERS

COMPOSITIONS AND METHODS FOR TREATING LIVER DISEASES WITH SIRNAS TARGETING GPAM

Process to Inhibit or Eliminate Eosinophilic Diseases of the Airway and Related Conditions

COMBINATION OF A GREMLIN-1 ANTAGONIST WITH AN INHIBITOR OF RAS-RAF-MEK-ERK SIGNALLING

COMPOSITIONS AND METHODS FOR ORGAN SPECIFIC DELIVERY OF NUCLEIC ACIDS

PREPARATION AND ANTI-TUMOR APPLICATION OF GENE THERAPY VECTOR INTERFERING CKLF-LIKE MARVEL TRANSMEMBRANE DOMAIN-CONTAINING PROTEIN 6 (CMTM6) EXPRESSION

LIPID CONJUGATES FOR THE DELIVERY OF THERAPEUTIC AGENTS TO CNS TISSUE

ANTISENSE NUCLEIC ACID CAPABLE OF INHIBITING BIOSYNTHESIS OF CHONDROITIN SULFATE

METHOD FOR CONSTRUCTING GENE NETWORK THROUGH SINGLE-CELL TRANSCRIPTOME AND METHOD FOR DISCOVERING KEY GENE IN DIFFERENTIATION USING SAME

MODIFIED DOUBLE-STRANDED OLIGONUCLEOTIDE MOLECULE, MODIFIED DOUBLE-STRANDED OLIGONUCLEOTIDE CONJUGATE, AND USE THEREOF

Nucleic acid regulation of ApoE

OLIGONUCLEOTIDES WITH 2'-DEOXY-2'-F-2'-C-METHYL NUCLEOTIDES

IMMUNE CELLS WITH COMBINATION GENE PERTURBATIONS

TRANS-VACCENIC ACID (TVA) AND DERIVATIVES THEREOF IN T CELL-BASED CANCER THERAPIES

IMMUNE CELLS HAVING CO-EXPRESSED TGFBR SHRNAS

COMPOSITIONS AND METHODS FOR TREATMENT OF DOMINANT RETINITIS PIGMENTOSA

ANTI-HELICASE THERAPY FOR TREATMENT OF REPEAT EXPANSION DISEASE

COMPOSITION FOR PREVENTION OR TREATMENT OF CANCER COMPRISING DDX54 INHIBITOR AND CANCER IMMUNOTHERAPY AGENT

RNAi Agents for Inhibiting Expression of Complement Factor B (CFB), Pharmaceutical Compositions Thereof, and Methods of Use

BRANCHED TRIPLE LIPID-MODIFIED NUCLEIC ACID COMPOUNDS

TREATING METASTATIC CANCER AND MODEL SYSTEMS FOR METASTATIC DISEASE

BICYCLIC HETEROCYCLES AND THEIR LIGANDS FOR TARGETED DELIVERY OF THERAPEUTIC AGENTS

NOVEL APPROACH FOR TREATMENT OF CANCER USING IMMUNOMODULATION

RNAi Agents for Inhibiting Expression of Activin Receptor-Like Kinase 7 (ALK7), Compositions Thereof, and Methods of Use

RNAI CONSTRUCTS FOR INHIBITING PNPLA3 EXPRESSION AND METHODS OF USE THEREOF

AMPHIREGULIN GENE-SPECIFIC DOUBLE-STRANDED OLIGONUCLEOTIDE AND COMPOSITION FOR PREVENTING AND TREATING FIBROSIS-RELATED DISEASES AND RESPIRATORY DISEASES, COMPRISING SAME

Use of Non-Coding Nucleic Acid for Crop Improvement and Protection Against Microbes

ASYMMETRIC RNA MOLECULES

MODIFIED RNA AGENTS WITH REDUCED OFF-TARGET EFFECT

METHODS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS

POLYNUCLEOTIDE AGENTS TARGETING COMPLEMENT COMPONENT C5 AND METHODS OF USE THEREOF

COMPOSITION FOR PREVENTING OR TREATING MYOCARDITIS, COMPRISING VLA-4 INHIBITOR

CRY PROTEIN CRYSTALS AND METHODS OF USE

LIPID NANOPARTICLES

COMPOSITIONS AND METHODS FOR MODULATING NaV1.8

MODIFIED RNA AGENTS WITH REDUCED OFF-TARGET EFFECT

Treatment Of Liver Disease With Mitochondrial Glycerol-3-Phosphate Acyltransferase (GPAM) Inhibitors

PHARMACEUTICAL COMPOSITION FOR TREATMENT OR PREVENTION OF FIBROTIC DISEASE

LNCRNA TRANSCRIPTS IN MELANOMAGENESIS

GALNAC COMPOSITIONS FOR IMPROVING SIRNA BIOAVAILABILITY

COMPOSITIONS AND METHODS FOR INHIBITING GENE EXPRESSION OF ALPHA-1 ANTITRYPSIN

COMPOSITIONS AND METHODS FOR THE TREATMENT OF ANGIOPOIETIN LIKE 7 (ANGPTL7) RELATED DISEASES

RNAi Agents of Modulating PLP1

SIRNA TARGETING ANGIOTENSINOGEN AND PHARMACEUTICAL USE OF SIRNA

LIPID NANOPARTICLES USED TO TRANSPORT NUCLEIC ACIDS INTO LYMPHATIC ENDOTHELIUM CELLS

COMPOSITIONS AND METHODS FOR IMPROVING PERSISTENCE OF CELLS FOR ADOPTIVE TRANSFER

METHODS AND COMPOSITIONS FOR TREATING TNNT2 RELATED CARDIOMYOPATHY WITH A VIRAL VECTOR

COMPOSITIONS AND METHODS OF TREATING MUSCLE ATROPHY AND MYOTONIC DYSTROPHY

PHOSPHORODIAMIDATE MORPHOLINO OLIGOMER CONJUGATES

IMMUNOTHERAPEUTIC CONSTRUCTS AND METHODS OF THEIR USE

GENE-REGULATING COMPOSITIONS AND METHODS FOR IMPROVED IMMUNOTHERAPY

METHODS OF TREATING CHOLANGIOCARCINOMA

LIPID PARTICLE, COMPOSITION CONTAINING LIPID PARTICLE, KIT CONTAINING LIPID PARTICLE, AND ACTIVE AGENT DELIVERY METHOD USING LIPID PARTICLE

COMPOSITIONS AND METHODS FOR MANAGEMENT OF WHITEFLY

METHODS OF DESIGNING CONDITIONAL-ACTIVATABLE SMALL INTERFERING RNA SENSORS

METHODS FOR IDENTIFYING THERAPEUTIC AGENTS

siRNA SUPPRESSING EXPRESSION OF TRANSFERRIN RECEPTOR 2

CHEMICALLY MODIFIED OLIGONUCLEOTIDE HAVING RNAi ACTIVITY

COMPOUNDS AND METHODS FOR REDUCING IFNAR1 EXPRESSION

KETOHEXOKINASE (KHK) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

TREATMENT AND DIAGNOSIS OF INFLAMMATORY DISORDERS

Methods Of Treating Liver Diseases With Phosphodiesterase 3B (PDE3B) Inhibitors

SARM1 RNA INTERFERENCE AGENTS

NONCOVALENTLY BRANCHED OLIGONUCLEOTIDE COMPOSITIONS

POLYNUCLEIC ACID MOLECULES TARGETING APOC3 AND USES THEREOF

POLYNUCLEIC ACID MOLECULES FOR INHIBITING EXPRESSION OF LP(A), PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF

FULLY STABILIZED ASYMMETRIC SIRNA

HIGH MOBILITY GROUP BOX-1 (HMGB1) IRNA COMPOSITIONS AND METHODS OF USE THEREOF

LIPOPHILIC OLIGONUCLEOTIDE CONJUGATES

SIGNAL ACTIVATABLE NUCLEIC ACID CONSTRUCTS WITH WOBBLE BASE PAIRINGS

CONDITIONALLY ACTIVATABLE NUCLEIC ACID COMPLEXES

ENHANCING ESTROGEN RECEPTOR ALPHA IN OSTEOARTHRITIS

MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING DYSTROPHINOPATHIES

BLOCK COPOLYMERS

Treatment Methods for Fibrosis Targeting SMOC2

PYK2 INHIBITION MODULATES IMMUNE CELL FUNCTION

TARGETING NEUROPILIN 2 (NRP2) IN LETHAL PROSTATE CANCER

USE OF CDK16 AS TARGET IN PREPARATION OF MEDICINE FOR TREATING TRIPLE-NEGATIVE BREAST CANCER

RNAI AGENT TARGETING MARC1 GENE, AND USE THEREOF

USE OF DINUCLEOTIDE REPEAT RNAS TO TREAT CANCER

TARGETED COMPOSITIONS

ATXN2 RNA INTERFERENCE AGENTS

SYSTEMS

IL-6 INHIBITOR AS TREATMENT FOR NEPHROPATHY

MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING DYSTROPHINOPATHIES

G ALPHA Q/11 INHIBITORS FOR USE AS AN ANALGESIC

TARGETING PTCHD1 AND NEURONAL CHOLESTEROL TO ENHANCE SAFETY OF OPIOID ANALGESICS

HIF-1 ACTIVATORS AND USES THEREOF

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE SIGNAL REGULATORY PROTEIN ALPHA (SIRPa) GENE

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE PCSK9 GENE

APPLICATION OF MECHANICAL-FORCE SENSITIVE MACROPHAGE SUBSET IN PANCREATIC CANCER DIAGNOSIS OR PROGNOSIS EVALUATION

Microtubule Associated Protein Tau (MAPT) iRNA Agent Compositions and Methods of Use Thereof

METHODS OF PREPARING HIGH CONCENTRATION LIQUID DRUG SUBSTANCES

NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF

GENE THERAPEUTICS FOR TREATING BONE DISORDERS

MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING DYSTROPHINOPATHIES

INHIBIN SUBUNIT BETA E INHIBITOR AND METHODS OF USE THEREOF

ULTRASOUND RESPONSIVE LIPID NANOPARTICLE CARRYING GENES AND CELL MEMBRANE, ITS PREPARATION METHOD AND APPLICATION

SIRNA SPECIFICALLY BINDING TO M2 MACROPHAGE CD206 AND APPLICATION THEREOF

METHOD FOR TREATING TUBULAR AGGREGATE MYOPATHY AND STORMORKEN SYNDROME

Promotion of Cardiomyocyte Proliferation and Regenerative Treatment of the Heart by Inhibition of microRNA-128

Brush polymer-oligonucleotide conjugates for the treatment of muscular dystrophy

COMPOSITIONS AND METHODS FOR IMPROVING STRAND BIASED

Therapeutic Inhibition of LPA Expression

CATIONIC LIPIDS FOR NUCLEIC ACID DELIVERY AND PREPARATION THEREOF

METHOD FOR IMPROVING AUDITORY PERCEPTION USING A VIPR1 INHIBITOR

DESIGN AND DEVELOPMENT OF A NOVEL MESSENGER RNA THERAPEUTIC TO TREAT ATHEROSCLEROSIS

BRAIN TUMOR MODEL

RNAI CONSTRUCTS FOR INHIBITING PNPLA3 EXPRESSION AND METHODS OF USE THEREOF

Products and Methods for Treatment of Amyotrophic Lateral Sclerosis

LINKAGE MODIFIED OLIGOMERIC COMPOUNDS AND USES THEREOF

GENETICALLY-MODIFIED IMMUNE CELLS COMPRISING A MICRORNA-ADAPTED SHRNA (SHRNAMIR)

MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING DYSTROPHINOPATHIES

METHOD FOR PREPARING LIPOSOMES

Methods and Compositions for RNA-Directed Target DNA Modification and For RNA-Directed Modulation of Transcription

Compositions and Methods for Enhancing AAV Therapy and Decreasing Tropism of AAV to the Liver

COMPOSITIONS AND METHODS OF TREATING AMYOTROPHIC LATERAL SCLEROSIS (ALS)

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF PREKALLIKREIN (PKK) PROTEIN

OLIGONUCLEOTIDES WITH ETHYLENE GLYCOL MODIFICATION

EGFL6 SPECIFIC MONOCLONAL ANTIBODIES AND METHODS OF THEIR USE

TREATMENT OF SMOKING WITH CHOLINERGIC RECEPTOR NICOTINIC BETA 3 SUBUNIT (CHRNB3) INHIBITORS

ANTI-PTEN RNA INTERFERENCE OLIGONUCLEOTIDES AND USES THEREOF

ANTISENSE OLIGONUCLEOTIDES TARGETING ADENOSINE KINASE

COMPOSITIONS AND METHODS COMPRISING ENGINEERED SHORT NUCLEAR RNA (SNRNA)

iRNA Compositions and Methods for Silencing ANGPTL4

NUCLEIC ACIDS FOR INHIBITING EXPRESSION OF COMPLEMENT FACTOR B (CFB) IN A CELL

USE OF ETV3 OR ETV6 INHIBITORS FOR BLOCKING THE DIFFERENTIATION OF MONOCYTES INTO DENDRITIC CELLS

NUCLEIC ACID MODIFIED BIOLOGICAL CELL WITH EXPANSION-DEPENDENT GENE EXPRESSION

COMPOSITIONS FOR EDITING MECP2 TRANSCRIPTS AND METHODS THEREOF

Treatment Of Myeloid Cell Dysfunction With Membrane Spanning 4-Domains A6A (MS4A6A) Inhibitors

COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING MSH2 OR MSH6 INHIBITOR AS ACTIVE INGREDIENT

NANOPARTICLE VECTOR FOR RNA SELF-DELIVERY, AND PREPARATION METHOD THEREFOR AND USE THEREOF

Treatment Of Osteoarthritis With Procollagen Galactosyl Transferase 2 (COLGALT2) Inhibitors

Treatment Of Macular Degeneration With Complement Factor D (CFD) Inhibitors

siRNA based on RNA sequence of SARS-CoV-2 and use thereof

Treatment Of Liver Disease Or Metabolic Disorder With Folliculin Interacting Protein 1 (FNIP1) Inhibitors And/Or Folliculin (FLCN) Inhibitors

EPO RECEPTOR AGONISTS AND ANTAGONISTS

EPO RECEPTOR AGONISTS AND ANTAGONISTS

CD71 BINDING FIBRONECTIN TYPE III DOMAINS

COMPOSITIONS AND METHODS FOR TREATING CANCERS

ASSESSMENT AND TREATMENT OF CHRONIC HEPATITIS B

MODULATION OF TGF BETA SIGNALING IN GENETICALLY-MODIFIED EUKARYOTIC CELLS

ANISAMIDE-CONTAINING LIPIDS AND COMPOSITIONS AND METHODS OF USE THEREOF

Methods and Compositions for RNA-Directed Target DNA Modification and for RNA-Directed Modulation of Transcription

DEPLETION OF FNDC5 REDUCES CANCER INDUCED MUSCLE LOSS/CACHEXIA

Modulation of TJPI Expression to Treat Liver Diseases

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE ALAS1 GENE

THERAPEUTIC SUPPRESSOR TRNA TO TREAT GENETIC DISEASES

ANTIVIRAL HAIRPIN CONSTRUCTS AND METHODS OF USE THEREOF

HIV PRE-IMMUNIZATION AND IMMUNOTHERAPY

METHODS OF PRODUCING CELLS RESISTANT TO HIV INFECTION

LIPID NANOPARTICLES

Treatment Of Uveitis With Endoplasmic Reticulum Aminopeptidase 1 (ERAP1) Inhibitors

MODULATORY POLYNUCLEOTIDES

MODULATION OF SUV39H1 EXPRESSION BY RNAS

METHOD FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF CANCER METASTASIS

COMPOSITIONS AND METHODS FOR INHIBITING GENE EXPRESSION OF LPA

LIPID NANOPARTICLE (LNP) COMPOSITIONS FOR BRAIN-SELECTIVE CARGO DELIVERY, AND METHODS OF USE THEREOF

THERAPY FOR POLYCYSTIC KIDNEY DISEASE

METHOD OF DELIVERY OF DNA OR RNA CARGO USING UNSHIELDED LIPID NANOPARTICLES AND COMPOSITIONS THEREOF

HIGH MOLECULAR WEIGHT MODIFIED RNA COMPOSITIONS